Cite Filings / AMLX / 0001193125-25-044765

Feed Companies Filings Check

Sign in

POSASR

Filing

Amylyx Pharmaceuticals, Inc. Filed 2025-03-04 Acc 0001193125-25-044765

Documents 1

POSASR , d892414dposasr.htm

Around this filing

2025-03-05 4 Co-Chief Executive Officer sold 4,595 shares at $3.15 ($14,483)
2025-03-05 UPLOAD SEC-generated Letter
2025-03-04 S-8 Securities Offered to Employees in Benefit Plans
2025-03-04 S-3 Registration Statement
2025-03-04 POSASR POSASR
2025-03-04 10-K Annual Report
2025-03-04 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d892414dposasr.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…